Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 6
2001 3
2002 3
2003 2
2004 2
2005 3
2006 3
2007 1
2008 4
2009 3
2010 1
2011 5
2012 3
2013 4
2014 3
2015 1
2016 5
2017 6
2018 10
2019 11
2020 9
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Simonneau G, et al. Eur Respir J. 2019 Jan 24;53(1):1801913. doi: 10.1183/13993003.01913-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545968 Free PMC article. Review.
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) 25 mmHg at rest, measured by right heart catheterisation. ...Prospective trials are required t …
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defin …
Pulmonary Complications of Portal Hypertension.
Cartin-Ceba R, Krowka MJ. Cartin-Ceba R, et al. Clin Liver Dis. 2019 Nov;23(4):683-711. doi: 10.1016/j.cld.2019.06.003. Epub 2019 Aug 9. Clin Liver Dis. 2019. PMID: 31563218 Review.
The most common pulmonary complications of chronic liver disease are hepatic hydrothorax, hepatopulmonary syndrome, and portopulmonary hypertension. Hepatic hydrothorax is a transudative pleural effusion in a patient with cirrhosis and no evidence of underlying card …
The most common pulmonary complications of chronic liver disease are hepatic hydrothorax, hepatopulmonary syndrome, and portopulmonary
Treatment Barriers in Portopulmonary Hypertension.
AbuHalimeh B, Krowka MJ, Tonelli AR. AbuHalimeh B, et al. Hepatology. 2019 Jan;69(1):431-443. doi: 10.1002/hep.30197. Epub 2018 Dec 18. Hepatology. 2019. PMID: 30063259 Free PMC article. Review.
Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH) that can develop as a complication of portal hypertension. ...
Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH) that can develop as a complicatio
Hepatopulmonary syndrome.
Gupta S, Krowka MJ. Gupta S, et al. CMAJ. 2018 Feb 26;190(8):E223. doi: 10.1503/cmaj.170253. CMAJ. 2018. PMID: 29483331 Free PMC article. No abstract available.
International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. Krowka MJ, et al. Transplantation. 2016 Jul;100(7):1440-52. doi: 10.1097/TP.0000000000001229. Transplantation. 2016. PMID: 27326810
Two distinct pulmonary vascular disorders, hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) may occur as a consequence of hepatic parenchymal or vascular abnormalities. ...Definitions/Diagnostic criteria; II. Hepatopulmonary syndrome; III. Po
Two distinct pulmonary vascular disorders, hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) may occur as …
Hepatopulmonary syndrome.
Fuhrmann V, Krowka M. Fuhrmann V, et al. J Hepatol. 2018 Sep;69(3):744-745. doi: 10.1016/j.jhep.2018.01.002. Epub 2018 Jun 28. J Hepatol. 2018. PMID: 29960651 No abstract available.
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.
Sitbon O, Bosch J, Cottreel E, Csonka D, de Groote P, Hoeper MM, Kim NH, Martin N, Savale L, Krowka M. Sitbon O, et al. Lancet Respir Med. 2019 Jul;7(7):594-604. doi: 10.1016/S2213-2600(19)30091-8. Epub 2019 Jun 6. Lancet Respir Med. 2019. PMID: 31178422 Clinical Trial.
BACKGROUND: No dedicated randomised clinical trials have evaluated therapies for pulmonary arterial hypertension in patients with portopulmonary hypertension. The endothelin receptor antagonist macitentan has demonstrated long-term efficacy in pulmonary arter …
BACKGROUND: No dedicated randomised clinical trials have evaluated therapies for pulmonary arterial hypertension in patients with …
Portopulmonary hypertension.
Cartin-Ceba R, Krowka MJ. Cartin-Ceba R, et al. Clin Liver Dis. 2014 May;18(2):421-38. doi: 10.1016/j.cld.2014.01.004. Epub 2014 Feb 25. Clin Liver Dis. 2014. PMID: 24679504 Review.
Portopulmonary hypertension (POPH) is the presence of pulmonary arterial hypertension in patients with portal hypertension. ...
Portopulmonary hypertension (POPH) is the presence of pulmonary arterial hypertension in patients with portal hypert
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations.
Nanchal R, Subramanian R, Karvellas CJ, Hollenberg SM, Peppard WJ, Singbartl K, Truwit J, Al-Khafaji AH, Killian AJ, Alquraini M, Alshammari K, Alshamsi F, Belley-Cote E, Cartin-Ceba R, Dionne JC, Galusca DM, Huang DT, Hyzy RC, Junek M, Kandiah P, Kumar G, Morgan RL, Morris PE, Olson JC, Sieracki R, Steadman R, Taylor B, Alhazzani W. Nanchal R, et al. Crit Care Med. 2020 Mar;48(3):e173-e191. doi: 10.1097/CCM.0000000000004192. Crit Care Med. 2020. PMID: 32058387
Portopulmonary hypertension.
Krowka MJ. Krowka MJ. Semin Respir Crit Care Med. 2012 Feb;33(1):17-25. doi: 10.1055/s-0032-1301731. Epub 2012 Mar 23. Semin Respir Crit Care Med. 2012. PMID: 22447257 Review.
Portopulmonary hypertension (POPH) refers to the presence of pulmonary arterial hypertension (PAH) in patients with portal hypertension. Pulmonary hypertension in patients with liver disease or portal hypertension can be due to multiple m
Portopulmonary hypertension (POPH) refers to the presence of pulmonary arterial hypertension (PAH) in patients with por
84 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page